Free Trial

Xeris Biopharma (XERS) Insider Trading & Ownership

Xeris Biopharma logo
$3.23
+0.01 (+0.31%)
(As of 11/1/2024 ET)

Xeris Biopharma (NASDAQ:XERS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.56%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$90,249.61
Number Of
Insiders Selling
(Last 12 Months)
0
Get XERS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xeris Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

XERS Insider Buying and Selling by Quarter

Xeris Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2024John P SchmidDirectorBuy4,285$2.37$10,155.45  
3/14/2024John P SchmidDirectorBuy4,500$2.16$9,720.00  
11/27/2023Jeffrey W ShermanDirectorBuy5,400$1.87$10,098.00  
11/17/2023John Patrick Shannon JrInsiderBuy30,769$1.64$50,461.16  
11/16/2023John P SchmidDirectorBuy6,500$1.51$9,815.00  
(Data available from 1/1/2013 forward)

XERS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Xeris Biopharma includes Jeffrey W Sherman, John P Schmid, John Patrick Shannon Jr, Paul R Edick, and Steven Prestrelski. Learn more on insiders at XERS.

4.56% of Xeris Biopharma stock is owned by insiders. Learn more on XERS's insider holdings.

The following insiders have purchased XERS shares in the last 24 months: Jeffrey W Sherman ($10,098.00), John P Schmid ($29,690.45), John Patrick Shannon Jr ($50,461.16), and Paul R Edick ($23,800.00).

Insiders have purchased a total of 61,454 XERS shares in the last 24 months for a total of $114,049.61 bought.



This page (NASDAQ:XERS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners